Abstract

Objectives: The risk for cervical cancer is related to sexual intercourse. One factor associated with tumor invasion and metastases is the production of matrix metalloproteinases, which degrade the extracellular matrix. The ability of human semen to influence production of messenger ribonucleic acid for 2 matrix metalloproteinases associated with cervical cancer, MMP-2 and MMP-9, was examined. Study Design: Seminal fluids from 16 men were diluted 1:50 and incubated with the cervical carcinoma cell line HeLa for 18 hours. Cells were harvested, ribonucleic acid was isolated and reverse transcribed into complementary deoxyribonucleic acid, and deoxyribonucleic acid sequences coding for regions of the genes for MMP-2 and MMP-9 were generated by polymerase chain reaction and detected by enzyme-linked immunosorbent assay. Results: All 16 semen samples inhibited production of MMP-2 messenger ribonucleic acid. The MMP-2 messenger ribonucleic acid synthesis in the presence of semen was a mean of 39.5% of the control value. In contrast, MMP-9 messenger ribonucleic acid synthesis was stimulated (mean stimulation, 68.3%) by semen in 10 of the 15 samples tested. Synthesis of β-actin was comparable in each culture, and cell viability was unaffected by the diluted semen. Conclusion: The capacity of semen to influence transcription of the genes for matrix metalloproteinases may be one mechanism whereby sexual activity influences cervical cancer progression. (Am J Obstet Gynecol 1999;181:591-5.)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.